BioNexus Gene Lab Corp Common stock (BGLC)

Price$2.20

Value ScoreC

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-59.47%

Price vs S&P 500 (4W)6.81%

VGM Score29.23

Market Capitalization$5.32M

All Metrics

Book Value / Share (Quarterly)$3.35

P/TBV (Annual)2.39x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-12.09%

Cash Flow / Share (Quarterly)$-0.49

Price vs S&P 500 (YTD)-52.26%

Gross Margin (TTM)12.22%

Net Profit Margin (TTM)-75.03%

EPS (TTM)$-1.47

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-1.47

Revenue Growth (5Y)-8.20%

EPS (Annual)$-1.61

ROI (Annual)-34.64%

Gross Margin (Annual)14.62%

Net Profit Margin (5Y Avg)-16.32%

Cash / Share (Quarterly)$0.55

Revenue Growth QoQ (YoY)-98.93%

ROA (Last FY)-32.26%

Revenue Growth TTM (YoY)-67.08%

EBITD / Share (TTM)$-1.38

ROE (5Y Avg)-15.20%

Operating Margin (TTM)-74.61%

Cash Flow / Share (Annual)$-0.78

P/B Ratio0.66x

P/B Ratio (Quarterly)0.64x

Net Income / Employee (Annual)$-331,600

EV / Revenue (TTM)1.32x

Net Interest Coverage (TTM)-41.45x

ROA (TTM)-32.88%

EV / EBITDA (TTM)36.68x

EPS Incl Extra (Annual)$-1.61

Current Ratio (Annual)10.46x

Quick Ratio (Quarterly)5.69x

3-Month Avg Trading Volume0.02M

52-Week Price Return-32.93%

Revenue / Employee (TTM)$338,900

Tangible BV / Share (Quarterly)$0.41

P/S Ratio (Annual)0.72x

Asset Turnover (Annual)0.80x

52-Week High$15.60

Operating Margin (5Y Avg)-15.63%

EPS Excl Extra (Annual)$-1.61

CapEx CAGR (5Y)-38.49%

Tangible BV CAGR (5Y)134.18%

26-Week Price Return-51.54%

Quick Ratio (Annual)9.16x

13-Week Price Return-16.03%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)6.52x

Enterprise Value$4.03M

Revenue / Share Growth (5Y)24.68%

Asset Turnover (TTM)0.35x

Book Value / Share Growth (5Y)50.12%

Revenue / Employee (Annual)$825,000

Inventory Turnover (Annual)6.14x

Pretax Margin (Annual)-40.20%

Cash / Share (Annual)$0.99

3-Month Return Std Dev59.30%

Gross Margin (5Y Avg)14.06%

Net Income / Employee (TTM)$-322,800

ROE (Last FY)-34.64%

Net Interest Coverage (Annual)-23.33x

EPS Basic Excl Extra (Annual)$-1.61

P/FCF (TTM)5.54x

Receivables Turnover (TTM)5.49x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-1.47

Receivables Turnover (Annual)7.89x

ROI (TTM)-37.36%

P/S Ratio (TTM)1.74x

Pretax Margin (5Y Avg)-15.72%

Revenue / Share (Annual)$4.00

Tangible BV / Share (Annual)$0.46

Price vs S&P 500 (52W)-57.29%

Year-to-Date Return-44.30%

5-Day Price Return-1.79%

EPS Normalized (Annual)$-1.61

ROA (5Y Avg)-13.38%

Net Profit Margin (Annual)-40.20%

Month-to-Date Return-5.17%

Cash Flow / Share (TTM)$-0.03

EBITD / Share (Annual)$-1.54

Operating Margin (Annual)-39.93%

ROI (5Y Avg)-15.22%

EPS Basic Excl Extra (TTM)$-1.47

P/TBV (Quarterly)2.67x

P/B Ratio (Annual)0.82x

Inventory Turnover (TTM)6.14x

Pretax Margin (TTM)-75.03%

Book Value / Share (Annual)$3.56

Price vs S&P 500 (13W)-24.29%

Beta2.21x

P/FCF (Annual)10.85x

Revenue / Share (TTM)$1.26

ROE (TTM)-37.43%

52-Week Low$1.92

vGradeC

gGradeF

mGradeD

vgmGradeD

Show chart for

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
BGLCBioNexus Gene Lab Corp Common stock	C	F	D	$2.20
NTRANatera, Inc. Common Stock	F	A	C	$215.31
DGXQuest Diagnostics Inc.	C	D	C	$200.29
LHLabcorp Holdings Inc.	C	D	C	$265.15
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	B	$125.61
CAICaris Life Sciences, Inc. Common Stock	F	A	D	$16.49
CELCCelcuity Inc. Common Stock	—	—	C	$88.28
RDNTRadNet, Inc. Common Stock	D	C	C	$54.34
VCYTVeracyte, Inc.	D	A	B	$48.73
GRALGRAIL, Inc. Common Stock	D	A	C	$59.98

About

BioNexus Gene Lab Corp supplies chemical raw materials to industrial, medical, automotive, and electronics manufacturers across Southeast Asia, while developing non-invasive liquid biopsy tests that analyze RNA to detect early disease biomarkers. The Company's blood-based tests are designed to reduce treatment costs and improve patient management through early disease identification.